Aurora Cannabis (ACB) Asset Writedowns and Impairment (2019 - 2025)

Aurora Cannabis (ACB) has reported Asset Writedowns and Impairment for 7 consecutive years, with -$381483.4 the latest figure, recorded in Q3 2025.

• In Q3 2025, Asset Writedowns and Impairment fell 100.0% year-over-year to -$381483.4; the TTM figure through Dec 2025 stood at $11.6 billion (changed 0.03% YoY), while the FY2024 annual figure was $10.6 million, up 164.41% from the prior year.
• Asset Writedowns and Impairment climbed to -$381483.4 in Q3 2025 per ACB's latest filing, from -$405886.5 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $11.6 billion in Q3 2024 and bottomed at -$139.0 million in Q1 2022.
• Historically, Asset Writedowns and Impairment has averaged $906.1 million across 5 years, with a median of -$94317.1 in 2024.
• Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment sank 3769.19% — and 2024, when it jumped 1269099.46%.
• Aurora Cannabis' Asset Writedowns and Impairment stood at $6.8 million in 2021, then surged by 775.09% to $59.4 million in 2022, then plunged by 101.54% to -$917494.5 in 2023, then surged by 55.76% to -$405886.5 in 2024, then advanced by 6.01% to -$381483.4 in 2025.
• Business Quant data shows ACB's Asset Writedowns and Impairment at -$381483.4 in Q3 2025, -$405886.5 in Q4 2024, and $11.6 billion in Q3 2024.